** Shares of genetic testing firm Tempus AI TEM.O fall 16.9% to $57.8 premarket
** Co posts Q4 revenue of $200.7 mln, missing analysts' estimates of $203.1 mln as per data compiled by LSEG
** TEM reports Q4 net loss of 18 cents/share vs analyst est of 20 cents/share
** Co forecasts 2025 revenue to be $1.24 bln; analysts on average expect annual revenue to be $1.04 bln
** Stock has risen 72.8% since its Nasdaq debut in June
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。